Published in Hum Hered on January 01, 2001
Reduced-median-network analysis of complete mitochondrial DNA coding-region sequences for the major African, Asian, and European haplogroups. Am J Hum Genet (2002) 6.02
Phylogenetic network for European mtDNA. Am J Hum Genet (2001) 3.26
The western and eastern roots of the Saami--the story of genetic "outliers" told by mitochondrial DNA and Y chromosomes. Am J Hum Genet (2004) 1.81
Striking differentiation of sub-populations within a genetically homogeneous isolate (Ogliastra) in Sardinia as revealed by mtDNA analysis. Hum Genet (2003) 1.32
Traces of early Eurasians in the Mansi of northwest Siberia revealed by mitochondrial DNA analysis. Am J Hum Genet (2002) 1.27
Finnish Disease Heritage II: population prehistory and genetic roots of Finns. Hum Genet (2003) 1.20
Mitochondrial DNA haplogroups in early-onset Alzheimer's disease and frontotemporal lobar degeneration. Mol Neurodegener (2010) 0.86
Genetic analysis of human remains found in two eighteenth century Yakut graves at At-Dabaan. Int J Legal Med (2003) 0.85
Sequence variation in the tRNA genes of human mitochondrial DNA. J Mol Evol (2005) 0.82
Mitochondrial DNA sequence variation in Finnish patients with matrilineal diabetes mellitus. BMC Res Notes (2012) 0.81
Mitochondrial DNA variation in the Viking age population of Norway. Philos Trans R Soc Lond B Biol Sci (2015) 0.78
Vestiges of an Ancient Border in the Contemporary Genetic Diversity of North-Eastern Europe. PLoS One (2015) 0.77
Mitochondrial DNA variant m.15218A > G in Finnish epilepsy patients who have maternal relatives with epilepsy, sensorineural hearing impairment or diabetes mellitus. BMC Med Genet (2013) 0.77
Point mutations associated with Leber hereditary optic neuropathy in a Latvian population. Mol Vis (2013) 0.75
Variations of mitochondrial DNA polymerase γ in patients with Parkinson's disease. J Neurol (2013) 0.75
A novel MTTT mutation m.15933G > A revealed in analysis of mitochondrial DNA in patients with suspected mitochondrial disease. BMC Med Genet (2017) 0.75
Phylogenetic network for European mtDNA. Am J Hum Genet (2001) 3.26
Demyelinating polyneuropathy in a patient with the tRNA(Leu)(UUR) mutation at base pair 3243 of the mitochondrial DNA. Neurology (1995) 2.05
Partial identity of the 2-oxoglutarate and ascorbate binding sites of prolyl 4-hydroxylase. J Biol Chem (1986) 1.75
A 3-year clinical follow-up of adult patients with 3243A>G in mitochondrial DNA. Neurology (2006) 1.58
The 2-oxoglutarate binding site of prolyl 4-hydroxylase. Identification of distinct subsites and evidence for 2-oxoglutarate decarboxylation in a ligand reaction at the enzyme-bound ferrous ion. Eur J Biochem (1984) 1.56
Ascorbate is consumed stoichiometrically in the uncoupled reactions catalyzed by prolyl 4-hydroxylase and lysyl hydroxylase. J Biol Chem (1984) 1.50
A novel mitochondrial DNA mutation and a mutation in the Notch3 gene in a patient with myopathy and CADASIL. J Mol Med (Berl) (2001) 1.46
Phylogenetic network of the mtDNA haplogroup U in Northern Finland based on sequence analysis of the complete coding region by conformation-sensitive gel electrophoresis. Am J Hum Genet (2000) 1.45
Human mtDNA sublimons resemble rearranged mitochondrial genoms found in pathological states. Hum Mol Genet (2000) 1.37
Treatment for mitochondrial disorders. Cochrane Database Syst Rev (2006) 1.31
Reduction of collagen production in keloid fibroblast cultures by ethyl-3,4-dihydroxybenzoate. Inhibition of prolyl hydroxylase activity as a mechanism of action. J Biol Chem (1987) 1.25
Phylogenetic analysis of mitochondrial DNA in patients with an occipital stroke. Evaluation of mutations by using sequence data on the entire coding region. Mutat Res (2001) 1.18
APP locus duplication in a Finnish family with dementia and intracerebral haemorrhage. J Neurol Neurosurg Psychiatry (2007) 1.17
Differences between collagen hydroxylases and 2-oxoglutarate dehydrogenase in their inhibition by structural analogues of 2-oxoglutarate. Biochem J (1985) 1.13
Partial purification and characterization of chick-embryo prolyl 3-hydroxylase. Biochem J (1979) 1.08
Hereditary dementia with intracerebral hemorrhages and cerebral amyloid angiopathy. Neurology (2004) 1.01
Mitochondrial DNA haplogroup U as a risk factor for occipital stroke in migraine. Lancet (1998) 1.01
Detection of meningeal fibrosis after subarachnoid haemorrhage by assaying procollagen propeptides in cerebrospinal fluid. J Neurol Neurosurg Psychiatry (1999) 1.01
Phylogenetic analysis of mtDNA haplogroup TJ in a Finnish population. J Hum Genet (2001) 1.01
Prevalence of large-scale mitochondrial DNA deletions in an adult Finnish population. Neurology (2005) 0.95
Transient increase in procollagen propeptides in the CSF after subarachnoid hemorrhage. Neurology (2000) 0.92
Causes of death in pedigrees with the 3243A>G mutation in mitochondrial DNA. J Neurol Neurosurg Psychiatry (2008) 0.92
Familial aggregation of Parkinson's disease in a Finnish population. J Neurol Neurosurg Psychiatry (2000) 0.92
Hearing impairment in patients with 3243A-->G mtDNA mutation: phenotype and rate of progression. Hum Genet (2001) 0.91
Prolyl 3-hydroxylase and 4-hydroxylase activities in certain rat and chick-embryo tissues and age-related changes in their activities in the rat. Biochem J (1979) 0.91
Turnover of prolyl hydroxylase tetramers and the monomer-size protein in chick-embryo cartilaginous bone and lung in vivo. Biochem J (1979) 0.91
Complex segregation analysis of Parkinson's disease in the Finnish population. Hum Genet (2001) 0.90
Analysis of mitochondrial DNA sequences in patients with isolated or combined oxidative phosphorylation system deficiency. J Med Genet (2006) 0.89
Rapid induction of meningeal collagen synthesis in the cerebral cisternal and ventricular compartments after subarachnoid hemorrhage. Acta Neurochir (Wien) (2001) 0.88
Increase of collagen synthesis and deposition in the arachnoid and the dura following subarachnoid hemorrhage in the rat. Biochim Biophys Acta (1999) 0.88
Frequency of mitochondrial DNA point mutations among patients with familial sensorineural hearing impairment. Eur J Hum Genet (2000) 0.87
High concentrations of procollagen propeptides in chronic subdural haematoma and effusion. J Neurol Neurosurg Psychiatry (2003) 0.86
Childhood encephalopathies and myopathies: a prospective study in a defined population to assess the frequency of mitochondrial disorders. Pediatrics (2000) 0.85
Mutations in EIF4G1 are not a common cause of Parkinson's disease. Eur J Neurol (2013) 0.85
Increased activities of antioxidant enzymes and decreased ATP concentration in cultured myoblasts with the 3243A-->G mutation in mitochondrial DNA. Biochim Biophys Acta (2000) 0.85
No association of the mitochondrial DNA A12308G polymorphism with increased risk of stroke in patients with the A3243G mutation. J Neurol Neurosurg Psychiatry (2004) 0.84
Mutations in CHMP2B are not a cause of frontotemporal lobar degeneration in Finnish patients. Eur J Neurol (2010) 0.84
Relative fitness of carriers of the mitochondrial DNA mutation 3243A > G. Eur J Hum Genet (2001) 0.84
Low prevalence of progranulin mutations in Finnish patients with frontotemporal lobar degeneration. Eur J Neurol (2008) 0.83
Connective tissue metabolites in serum as markers of disease activity in patients with rheumatoid arthritis. Clin Exp Rheumatol (1988) 0.82
Parkinsonism associated with the homozygous W748S mutation in the POLG1 gene. Parkinsonism Relat Disord (2008) 0.80
Synthesis of collagen: chemical regulation of post-translational events. Ciba Found Symp (1985) 0.80
Chromosome 19q13 and multiple sclerosis susceptibility in Finland: a linkage and two-stage association study. J Neuroimmunol (2002) 0.80
Restriction fragment analysis as a source of error in detection of heteroplasmic mtDNA mutations. Mutat Res (1999) 0.80
Mitochondrial DNA deletion diagnosed by analysis of an endomyocardial biopsy specimen from a patient with Kearns-Sayre syndrome and complete heart block. Br Heart J (1992) 0.79
Ubiquinone and nicotinamide treatment of patients with the 3243A-->G mtDNA mutation. Neurology (2002) 0.78
Modifier locus for mitochondrial DNA disease: linkage and linkage disequilibrium mapping of a nuclear modifier gene for maternally inherited deafness. Genet Med (2001) 0.78
Haplotype-matched controls as a tool to discriminate polymorphisms from pathogenic mutations in mtDNA. Hum Genet (1999) 0.77
Increased risk of sensorineural hearing loss and migraine in patients with a rare mitochondrial DNA variant 4336A>G in tRNAGln. J Med Genet (2001) 0.77
Voxelwise analysis of diffusion tensor imaging and structural MR imaging in patients with the m.3243A>G mutation in mitochondrial DNA. AJNR Am J Neuroradiol (2011) 0.76
A two-stage study on multiple sclerosis susceptibility and chromosome 2q33. Genes Immun (2004) 0.76
Familial aggregation of cervical artery dissection and cerebral aneurysm. Stroke (1994) 0.76
Specific non-enzymatic glycation of the rat histone H1 nucleotide binding site in vitro in the presence of AlF4-. A putative mechanism for impaired chromatin function. Biochim Biophys Acta (1993) 0.76
Molecular genetic analysis of the alpha-synuclein and the parkin gene in Parkinson's disease in Finland. Eur J Neurol (2002) 0.76
Adult-onset diabetes mellitus and neurosensory hearing loss in maternal relatives of MELAS patients in a family with the tRNA(Leu(UUR)) mutation. Neurology (1993) 0.75
Effect of prevention of procollagen triple-helix formation on proline 3-hydroxylation in freshly isolated chick-embryo tendon cells. Biochem J (1981) 0.75
Regulation of proline 3-hydroxylation and prolyl 3-hydroxylase and 4-hydroxylase activities in transformed cells. Biochem J (1982) 0.75
Variations of mitochondrial DNA polymerase γ in patients with Parkinson's disease. J Neurol (2013) 0.75
Labelling of prolyl hydroxylase tetrameric subunits in freshly isolated chick-embryo tendon cells and in certain chick-embryo tissues in vivo. Biochem J (1982) 0.75
Epidemiology of the mitochondrial DNA 8344A>G mutation for the myoclonus epilepsy and ragged red fibres (MERRF) syndrome. J Neurol Neurosurg Psychiatry (2003) 0.75
Interference of AlF4- with nucleotide and DNA binding of rat histone H1 in vitro. Implications for the pathogenesis of Alzheimer's disease. Neurosci Lett (1991) 0.75
Kearns-Sayre syndrome case presenting a mitochondrial DNA deletion with unusual direct repeats and a rudimentary RNAase mitochondrial ribonucleotide processing target sequence. Genomics (1993) 0.75
The Finnish speech-in-noise test in MELAS mutation and other sensorineural hearing impairments. Scand Audiol Suppl (2001) 0.75